TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
LONA

LeonaBio, Inc.

Healthcare · Biotechnology

3.30$ -34.9% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns LeonaBio, Inc. (LONA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 50.2% of the shares are freely tradable; institutional investors hold 70.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 70.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 50.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 9Mio.

Largest Shareholders

Institutions

Institutions LONA
Name Stake (%) Shares Change (%) Date
Perceptive Advisors LLC 19.73 1,859,322 +0.0 06/30/2026
Kalehua Capital Management LLC 8.36 787,402 +100.0 03/31/2026
ADAR1 Capital Management LLC 7.72 727,481 +84.8 03/31/2026
COMMODORE CAPITAL LP 4.93 464,398 +0.0 03/31/2026
TCG Crossover Management, LLC 4.93 464,398 +0.0 06/30/2026
NEA Management Company, LLC 4.93 464,398 +0.0 03/31/2026
Spruce Street Capital LP 4.18 393,701 +0.0 06/30/2026
Adage Capital Partners Gp LLC 3.18 300,000 +0.0 06/30/2026
Vanguard Capital Management, LLC 2.07 194,760 +0.0 03/31/2026

Funds

Funds LONA
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.95 183,259 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?